Testing is often the beginning—not the end—of care
A patient purchases an at-home diagnostic product.
The test produces a result.
Then what?
In many consumer testing experiences, the healthcare workflow stops at exactly the moment the patient most needs help interpreting what happens next.
A test-to-treat model is designed to connect those steps.
What is test-to-treat?
Test-to-treat is an integrated care model in which diagnostic information can flow directly into an appropriate clinical evaluation and, when medically indicated, treatment.
A connected digital pathway may look like:
The clinical evaluation remains essential.
A diagnostic result is typically one input among symptoms, history, medications, allergies and risk factors.
Why test-to-treat matters
At-home diagnostics dramatically improve convenience.
But convenience alone does not solve healthcare fragmentation.
Patients may still have to:
- locate a provider
- repeat their health information
- explain which test they used
- communicate the result
- find a pharmacy
- manage follow-up
A connected pathway can reduce those handoffs.
Step 1: Activate the diagnostic
A QR or Data Matrix code can identify the product and launch the correct workflow.
The system can capture information such as:
- UUID
- product
- lot
- expiration
- test type
This creates traceability from the physical product into the digital care journey.
Step 2: Capture the result
Depending on the test, the result may be:
- digitally transmitted
- photographed
- interpreted with supported computer vision
- self-attested
- reviewed by a clinician
Invalid or ambiguous results should branch into retesting or review rather than being treated as definitive.
Step 3: Add clinical context
The platform can collect information relevant to the specific clinical protocol.
For a urinary-health pathway, that might include:
- symptoms
- onset
- severity
- prior infections
- medications
- allergies
- pregnancy possibility
- red flags
- STI or vaginal symptoms
This is where the diagnostic result becomes part of a broader clinical picture.
Step 4: Apply eligibility and safety gates
Not every patient should move into a simplified digital treatment pathway.
The workflow may identify situations requiring:
- synchronous care
- additional testing
- in-person evaluation
- urgent care
- emergency escalation
The objective is to make digital access more convenient without ignoring clinical boundaries.
Step 5: Clinician evaluation
A licensed provider reviews the relevant information and determines whether treatment is appropriate.
The provider—not the test and not the AI system—makes the medical decision.
AI may help:
- organize data
- identify exceptions
- surface protocol conflicts
- flag risk factors
- support workflow routing
But clinical authority remains with the treating professional.
Step 6: Electronic prescribing
If medication is clinically appropriate, the provider can create an electronic prescription through the clinical EHR.
The prescription can then be routed to the patient’s selected pharmacy.
Modern e-prescribing infrastructure makes this possible across broad retail pharmacy networks.
Step 7: Follow-up
The care pathway should not necessarily end when the prescription is sent.
Digital follow-up can evaluate:
- symptom improvement
- persistent symptoms
- adverse reactions
- recurrent symptoms
- additional care needs
This helps close the loop.
Test-to-treat as infrastructure
The most important insight is that test-to-treat is not one feature.
It is an orchestration problem involving:
- diagnostics
- identity
- clinical protocols
- telehealth
- EHR
- pharmacy
- notifications
- support
- analytics
- compliance
HealthCloudOS and SafeCDx are designed to coordinate those layers through a common platform.
From product to healthcare access point
For consumer health companies, diagnostic manufacturers and retailers, test-to-treat creates a significant shift.
A product can become the entry point into a connected healthcare experience.
Instead of:
the experience can become:
That is a fundamentally different consumer-health model.